Investment Type: Venture Capital
Mentions in press and media 2
| Date | Title | Description |
| 07.09.2022 | Sangel Capital Founder Receives Title of China's Top Early-Stage Investor from ChinaVenture Awards | SHENZHEN, China, Sept. 7, 2022 /PRNewswire/ -- Sangel Capital ("Sangel" or the "Company"), a leading biotech and healthcare venture capital company based in China, has announced that Liu Mulong, Founding Partner with the... |
| 21.09.2021 | Long-termism as Investment Philosophy: Healthcare Investor Sangel Capital Expects to See Big Rise in Investment Value | SHENZHEN, China, Sept. 20\1, 2021 /PRNewswire/ -- The portfolio value of Sangel Capital ("Sangel" or the "Company"), a leading biotech and healthcare venture capital company based in China, is poised for strong growth as... |